DUBLIN--(BUSINESS WIRE)--The "Immunoassay Systems - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets.
This report analyzes the worldwide markets in US$ Thousand by the following Technology Segments:
- Enzyme Immunoassay
- Fluorescence Immunoassay
- Chemiluminescence Immunoassay
- Rapid Tests
- ELISPOT
- PCR
- Others
The report profiles 65 companies including many key and niche players such as:
- Abbott Laboratories (USA)
- Beckman Coulter, Inc. (USA)
- bioMrieux SA (France)
- Bio-Rad Laboratories Inc. (USA)
- DiaSorin S.p.A (Italy)
- Fujirebio, Inc. (Japan)
- Ortho-Clinical Diagnostics, Inc. (USA)
- Roche Diagnostics (Switzerland)
- Siemens Healthineers (USA)
- Sysmex Corporation (Japan)
- Quidel Corporation (USA)
- Tosoh Bioscience, Inc. (USA)
Key Topics Covered
1. Industry Overview
2. Competitive Landscape
3. Market Trends and Issues
4. Macro Growth Drivers and Application Markets
5. Conceptual Overview
6. Product Launches
Approvals
7. Recent Industry Activity
8. Focus on Select Market Participants
9. Global Market Perspective
Total Companies Profiled: 65 (including Divisions/Subsidiaries 88)
- The United States (49)
- Canada (1)
- Japan (7)
-
Europe (29)
- France (3)
- Germany (6)
- The United Kingdom (5)
- Italy (3)
- Spain (1)
- Rest of Europe (11)
- Asia-Pacific (Excluding Japan) (2)
For more information about this report visit https://www.researchandmarkets.com/research/2kh5g4/immunoassay?w=4
